Nitrosourea and nitrosocarbamate derivatives of the antiestrogen tamoxifen as potential estrogen receptor-mediated cytotoxic agents in human breast cancer cells
- 1 June 1986
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 7 (2) , 77-90
- https://doi.org/10.1007/bf01806792
Abstract
We have prepared two analogs of the antiestrogen tamoxifen that incorporate known DNA-crosslinking functions, a chloroethyl nitrosourea and a nitrosocarbamate moiety, and we have tested their bioactivities in cultures of human breast cancer cells. Both compounds bind to the estrogen receptor from MCF-7 cells, with relative binding affinities of 0.18% for the nitrosocarbamate derivative and 0.35% for the nitrosourea derivative, while the affinity of tamoxifen is 1.8%, and that of estradiol is set at 100%. The tamoxifen-nitrosocarbamate compound demonstrated a dose-related cytotoxicity by the colony formation and cell proliferation assays that was not blocked by estradiol in either estrogen receptor-positive MCF-7 cells or estrogen receptor-negative MDA-MB-231 cells, and thus, was not studied further. Tamoxifen-nitrosourea (TAM-NU) showed dose-related cytotoxicity in MCF-7 cells that was blocked by estradiol, whereas its activity in MDA-MB-231 cells was unaffected by estradiol. N-2-(4-t-butylphenoxy)ethyl-N′-chloroethyl-N′-nitrosourea (BPE-NU), a control compound which contains the nitrosourea moiety but does not bind to the estrogen receptor, had no effect on cell proliferation or colony formation in MCF-7 cells, but was very inhibitory in the receptor-negative MDA-MB-231 cells. In contrast, TAM-NU was more active in the receptor-positive MCF-7 cells than in the MDA-MB-231 line. Thus, because TAM-NU appears to be active selectively against the receptor-positive cell line, and because this activity is suppressible by estradiol, its cytotoxic effect seems to be mediated via the estrogen receptor. However, since TAM-NU is active only in prolonged treatment protocols, it appears likely that its cytotoxic activity results from the hormone antagonistic effect of the hydrolysis product of TAM-NU (bis-desmethyltamoxifen), rather than from a direct receptor-mediated, DNA-directed cytotoxic action of TAM-NU itself. This study stresses the need for the use of appropriate control compounds and cell systems in order to assess whether the toxic activity displayed by hormone-cytotoxic conjugates is mediated by receptor interactions and whether it operates through the intended toxic mechanism.Keywords
This publication has 24 references indexed in Scilit:
- Antiestrogen action in breast cancer cells: Modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sitesBreast Cancer Research and Treatment, 1985
- Differential growth inhibition of cultured mammalian cells: Comparison of clinical antitumour agents and amsacrine derivativesEuropean Journal of Cancer and Clinical Oncology, 1984
- BIOACTIVITIES, ESTROGEN-RECEPTOR INTERACTIONS, AND PLASMINOGEN ACTIVATOR-INDUCING ACTIVITIES OF TAMOXIFEN AND HYDROXYTAMOXIFEN ISOMERS IN MCF-7 HUMAN-BREAST CANCER-CELLS1984
- Considerations in the design and evaluation of cytotoxic estrogensBreast Cancer Research and Treatment, 1982
- Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifenThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- 16-ALPHA-[BR-77]BROMO-11 BETA-METHOXYESTRADIOL-17-BETA - A GAMMA-EMITTING ESTROGEN IMAGING AGENT WITH HIGH UPTAKE AND RETENTION BY TARGET ORGANS1982
- Carrier-dependent and carrier-independent transport of anti-cancer alkylating agentsNature, 1981
- Cytotoxic estrogens in hormone receptive tumorsJournal of Toxicology and Environmental Health, 1981
- Synthesis of steroidal nitrosoureas with antitumor activityJournal of Medicinal Chemistry, 1979
- Differential response by human melanoma cells to 1,3-bis-(2-chloroethyl)-1-nitrosourea and bleomycinMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1973